2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Speakers - CRDWC 2025

Aliyah Dalier, Cancer R&D World Conference, Boston, Massachusetts, USA

Aliyah Dalier

Aliyah Dalier

  • Designation: University of Massachusetts Amherst
  • Country: USA

Biography

Aliyah Dalier is a PhD student in the Molecular and Cellular Biology Program at the University of Massachusetts Amherst. In the Arcaro lab, her research focuses on using genome-wide DNA methylation as a biomarker for breast cancer risk, specifically in high-risk individuals. Since not all high-risk individuals will develop breast cancer, her work aims to identify personalized risk factors based on an individual's epigenome. She uses breastmilk as a non-invasive liquid biopsy, isolating DNA from bilateral breastmilk samples from high-risk participants with a pathogenic germline BRCA mutation and performing DNA methylation to predict breast cancer risk in these populations.